Exhibit 4.4
WARRANT AGREEMENT
between
MAXPRO CAPITAL ACQUISITION CORP.
and
CONTINENTAL STOCK TRANSFER & TRUST COMPANY
This Warrant Agreement (this “Agreement”), is made as of October 7, 2021, between Maxpro Capital Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a limited purpose trust company, as warrant agent (in such capacity, the “Warrant Agent”).
WHEREAS, the Company is engaged in an initial public offering (the “Public Offering”) of units of the Company’s equity securities, each such unit comprised of one share of Class A common stock of the Company, par value $0.0001 per share (“Common Stock”), and one redeemable Public Warrant (as defined below) (the “Public Units”) and, in connection therewith, has determined to issue and deliver up to 9,000,000 warrants (or up to 10,350,000 warrants if the Over-allotment Option (as defined below) is exercised in full) to public investors in the Offering (the “Public Warrants”). Each Warrant entitles the holder thereof to purchase one share of Common Stock for $11.50 per share, subject to adjustment as described herein; and
WHEREAS, on October 7, 2021the Company entered into that certain Placement Unit Purchase Agreement with MP One Investment LLC, a Delaware limited liability company (the “Sponsor”), pursuant to which the Sponsor agreed to purchase an aggregate of 420,275 private placement units (or up to 464,150 private placement units if the underwriters in the Offering exercise their Over-allotment Option in full) simultaneously with the closing of the Offering (and the closing the Over-allotment Option, if applicable) (the “Private Placement Units” and, together with the Public Units, the “Units”) at a purchase price of $10.00 per Unit, and, in connection therewith, will issue and deliver up to an aggregate of 420,275 warrants (or up to 464,150 warrants if the Over-allotment Option is exercised in full) underlying such Private Placement Units bearing the legend set forth in Exhibit B hereto (“Private Placement Warrants”); and
WHEREAS, in order to finance the Company’s transaction costs in connection with an intended initial Business Combination (as defined below), the Sponsor or an affiliate of the Sponsor or certain of the Company’s executive officers and directors may, but are not obligated to, loan to the Company funds as the Company may require, of which up to $1,500,000 of such loans may be convertible into up to an additional 150,000 Units at a price of $10.00 per Unit, and, in connection therewith, will issue and deliver up to an aggregate of 150,000 warrants (the “Working Capital Warrants”); and
WHEREAS, in order to extend the period of time the Company has to consummate a Business Combination (defined below) as described in the Prospectus (defined below), the Sponsor or its affiliates or designees may, but are not obligated to, loan the Company funds as the Company may require to extend the period in which the Company must complete its initial business combination twice, for an additional three months each time, up to 18 months, for each three month extension $900,000, or $1,035,000 if the underwriters’ over-allotment option is exercised in full ($0.10 per unit in either case), of which up to $1,800,000, or $2,070,000 if the underwriters’ over-allotment option is exercised in full, of such loans may be convertible into up to an additional 180,000 units, or 207,000 units if underwriters’ over-allotment option is exercised in full, at a price of $10.00 per unit, and, in connection therewith, will issue and deliver up to an aggregate of 180,000 warrants, or 207,000 warrants underwriters’ over-allotment option is exercised in full, (the “Extension Warrants”); and
WHEREAS, following consummation of the Offering, the Company may issue additional warrants (“Post IPO Warrants,” and, together with the Private Placement Warrants, the Working Capital Warrants, the Extension Warrants and the Public Warrants, the “Warrants”) in connection with, or following the consummation by the Company of, a Business Combination (defined below); and
WHEREAS, the Company has filed with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-1, File No. 333-258091 (the “Registration Statement”) and prospectus (the “Prospectus”), for the registration, under the Securities Act of 1933, as amended (the “Securities Act”), of the Public Units, and the Public Warrants and the Common Stock included in the Public Units; and